138 related articles for article (PubMed ID: 31113607)
1. Celastrol Attenuates Intrahepatic Cholestasis of Pregnancy by Inhibiting Matrix Metalloproteinases-2 and 9.
Guo J; Wang Y; Wang N; Bai Y; Shi D
Ann Hepatol; 2019; 18(1):40-47. PubMed ID: 31113607
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate ameliorates intrahepatic cholestasis of pregnancy by inhibiting matrix metalloproteinase-2 and matrix metalloproteinase-9.
Zhang M; Xu M
Fundam Clin Pharmacol; 2017 Oct; 31(5):526-533. PubMed ID: 28477356
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol reduces matrix metalloproteinases and alleviates intrahepatic cholestasis of pregnancy in rats.
Chen Z; Hu L; Lu M; Shen Z
Can J Physiol Pharmacol; 2016 Apr; 94(4):402-7. PubMed ID: 26913826
[TBL] [Abstract][Full Text] [Related]
4. Identification of Matrix Metalloproteinase-2 and 9 as Biomarker of Intrahepatic Cholestasis of Pregnancy.
Chen Z; Shen Z; Hu L; Lu M; Feng Y
Ann Hepatol; 2017; 16(2):291-296. PubMed ID: 28233754
[TBL] [Abstract][Full Text] [Related]
5. Celastrol attenuates symptoms of preeclampsia in rats by inhibiting matrix metalloproteinase-9.
Xiao S; Zhang M; He Z; Wang D
Eur J Pharmacol; 2018 Jul; 830():33-38. PubMed ID: 29694830
[TBL] [Abstract][Full Text] [Related]
6. Magnesium sulphate can alleviate oxidative stress and reduce inflammatory cytokines in rat placenta of intrahepatic cholestasis of pregnancy model.
Han F; Xu L; Huang Y; Chen T; Zhou T; Yang L
Arch Gynecol Obstet; 2018 Sep; 298(3):631-638. PubMed ID: 30039470
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and therapeutic profiles of serum bile acids in women with intrahepatic cholestasis of pregnancy-a pseudo-targeted metabolomics study.
Cui Y; Xu B; Zhang X; He Y; Shao Y; Ding M
Clin Chim Acta; 2018 Aug; 483():135-141. PubMed ID: 29709452
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
[TBL] [Abstract][Full Text] [Related]
9. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
Vasavan T; Deepak S; Jayawardane IA; Lucchini M; Martin C; Geenes V; Yang J; Lövgren-Sandblom A; Seed PT; Chambers J; Stone S; Kurlak L; Dixon PH; Marschall HU; Gorelik J; Chappell L; Loughna P; Thornton J; Pipkin FB; Hayes-Gill B; Fifer WP; Williamson C
J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
[TBL] [Abstract][Full Text] [Related]
10. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
Kowalska-Kańka A; Maciejewski T; Niemiec KT
Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
[TBL] [Abstract][Full Text] [Related]
11. The role of Ca
Pan D; Jiang M; Tao G; Shi J; Song Z; Chen R; Wang D
J Obstet Gynaecol; 2024 Dec; 44(1):2345276. PubMed ID: 38685831
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q 10 supplementation: A potential therapeutic option for the treatment of intrahepatic cholestasis of pregnancy.
Martinefski MR; Rodriguez MR; Buontempo F; Lucangioli SE; Bianciotti LG; Tripodi VP
Eur J Pharmacol; 2020 Sep; 882():173270. PubMed ID: 32534074
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cholestasis of pregnancy.
den Dulk M; Valentijn RM; Welten CA; Beyer GP
Neth J Med; 2002 Oct; 60(9):366-9. PubMed ID: 12572710
[TBL] [Abstract][Full Text] [Related]
14. [Clinical practice guidelines of the Team of Experts of the Polish Gynecological Society: management of the intrahepatic cholestasis of pregnancy].
Leszczyńska-Gorzelak B; Oleszczuk J; Marciniak B; Poreba R; Oszukowski P; Wielgoś M; Czajkowski K;
Ginekol Pol; 2012 Sep; 83(9):713-7. PubMed ID: 23342903
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and Specificity of Biochemical Tests for Diagnosis of Intrahepatic Cholestasis of Pregnancy.
Jurate K; Rimantas Z; Jolanta S; Vladas G; Limas K
Ann Hepatol; 2017; 16(4):569-573. PubMed ID: 28611260
[TBL] [Abstract][Full Text] [Related]
16. Validation of MAPK signalling pathway as a key role of paeoniflorin in the treatment of intrahepatic cholestasis of pregnancy based on network pharmacology and metabolomics.
Wang J; Wen J; Ma X; Yang J; Zhang Z; Xie S; Wei S; Jing M; Li H; Lang L; Zhou X; Zhao Y
Eur J Pharmacol; 2022 Nov; 935():175331. PubMed ID: 36273619
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
Grymowicz M; Czajkowski K; Smolarczyk R
Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
[TBL] [Abstract][Full Text] [Related]
18. [Study on relationship between expression of familial intrahepatic cholestasis 1 mRNA in placenta and Intrahepatic cholestasis of pregnancy].
Xu Z; Ke JC; Xing AY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):430-3. PubMed ID: 18575333
[TBL] [Abstract][Full Text] [Related]
19. Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling.
Zhao Q; Liu F; Cheng Y; Xiao XR; Hu DD; Tang YM; Bao WM; Yang JH; Jiang T; Hu JP; Gonzalez FJ; Li F
Mol Cell Proteomics; 2019 Mar; 18(3):520-533. PubMed ID: 30617157
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
